Trump Signs US Appropriations-COVID Relief Bill With Cosmetics, Cannabis, Dietary Provisions
Executive Summary
The Consolidated Appropriations Act, H.R. 133, includes $900bn in unemployment relief to COVID victims as well as regular federal appropriations to avoid a looming government shutdown. US FDA provisions include cosmetics and nutrition industry mentions.
You may also be interested in...
CBD Class-Action Litigants Watching For Retroactive Effects In US FDA’s Awaited Rulemaking
Even in the “highly unlikely event” that the FDA does make CBD supplements legal, it will not do so retroactively, according to plaintiffs against CV Sciences in California’s Central District. However, the federal court, which also is hearing a similar case against competitor Charlotte’s Web, is not convinced.
NGOs To Assert COVID-Unsafe Cosmetic Ingredients In Next US Legislative Reform Push
The Campaign for Safe Cosmetics, powered by Breast Cancer Prevention Partners and the Environmental Working Group, intends to present the 117th Congress with links between cosmetic ingredients and increased COVID susceptibility as part of its push for tighter cosmetics industry oversight.
US FDA Guidance Scratches Sesame Labeling Itch; House Passes ‘FASTER’ Allergen Identity Process
Food Allergy Safety, Treatment, Education, and Research Act would amend FDA regulations to include sesame as major allergen and allow agency to add other food ingredients as major allergens based on prevalence and severity of allergic reactions. FDA, meanwhile, published guidance for voluntarily labeling sesame as an allergen while it develop its factors for evaluating which food allergens in addition to the eight already specified in its regulations should be designated as requiring additional controls, including allergen labeling.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: